Industry-Related Seminars – 17 October 2018

Using Cellular Impedance Assays for the Discovery and Development of Novel Cancer Immunotherapies and Chemotherapies

Dr. Brandon Lamarche
Senior Scientist of Acea Biosciences, San Diego, USA

CD226 is a novel signalling domain for chimeric antigen receptors

Dr. Dang L. Vu
Senior Research Scientist for Tessa Therapeutics Pte Ltd

Date: Wednesday, 17 October, 2018
Time: 9:15am – 11:45am
Venue: MD3, Level 2, Lecture Theatre
Chairperson: Dr Deron Herr